Literature DB >> 10070748

Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.

K Ogura1, K Nagata, H Hatanaka, H Habuchi, K Kimata, S Tate, M W Ravera, M Jaye, J Schlessinger, F Inagaki.   

Abstract

Fibroblast growth factors (FGFs) bind to extracellular matrices, especially heparin-like carbohydrates of heparan-sulfate proteoglycans which stabilize FGFs to protect against inactivation by heat, acid, proteolysis and oxidation. Moreover, binding of FGFs to cell surface proteoglycans promotes to form oligomers, which is essential for receptor oligomerization and activation. In the present study, we determined the solution structure of acidic FGF using a series of triple resonance multi-dimensional NMR experiments and simulated annealing calculations. Furthermore, we prepared the sample complexed with a heparin-derived hexasaccharide which is a minimum unit for aFGF binding. From the chemical shift differences between free aFGF and aFGF-heparin complex, we concluded that the major heparin binding site was located on the regions 110-131 and 17-21. The binding sites are quite similar to those observed for bFGF-heparin hexasaccharide complex, showing that both FGFs recognize heparin-oligosaccharides in a similar manner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070748     DOI: 10.1023/a:1008330622467

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  38 in total

1.  X-ray crystal structure of human acidic fibroblast growth factor.

Authors:  M Blaber; J DiSalvo; K A Thomas
Journal:  Biochemistry       Date:  1996-02-20       Impact factor: 3.162

2.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo.

Authors:  E G Nabel; Z Y Yang; G Plautz; R Forough; X Zhan; C C Haudenschild; T Maciag; G J Nabel
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

3.  High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy.

Authors:  F J Moy; A P Seddon; P Böhlen; R Powers
Journal:  Biochemistry       Date:  1996-10-22       Impact factor: 3.162

4.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

Review 5.  More to "heparin" than anticoagulation.

Authors:  U Lindahl; K Lidholt; D Spillmann; L Kjellén
Journal:  Thromb Res       Date:  1994-07-01       Impact factor: 3.944

6.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

7.  Further characterization of the antithrombin-binding sequence in heparin.

Authors:  L Thunberg; G Bäckström; U Lindahl
Journal:  Carbohydr Res       Date:  1982-03-01       Impact factor: 2.104

8.  Secondary structure determination by NMR spectroscopy of an immunoglobulin-like domain from the giant muscle protein titin.

Authors:  M Pfuhl; M Gautel; A S Politou; C Joseph; A Pastore
Journal:  J Biomol NMR       Date:  1995-07       Impact factor: 2.835

9.  Recombinant basic fibroblast growth factor accelerates wound healing.

Authors:  G S McGee; J M Davidson; A Buckley; A Sommer; S C Woodward; A M Aquino; R Barbour; A A Demetriou
Journal:  J Surg Res       Date:  1988-07       Impact factor: 2.192

10.  Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation.

Authors:  O Saksela; D Moscatelli; A Sommer; D B Rifkin
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

View more
  10 in total

1.  Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.

Authors:  Alphonse I Arunkumar; Thallampuranam Krishnaswamy S Kumar; Karuppanan Muthusamy Kathir; Sampath Srisailam; Han-Min Wang; Philominathan Sagaya Theresa Leena; Ya-Hui Chi; Ho-Chz Chen; Chieh-Hsi Wu; Rong-Tsun Wu; Gu-Gang Chang; Ing-Ming Chiu; Chin Yu
Journal:  Protein Sci       Date:  2002-05       Impact factor: 6.725

2.  Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods.

Authors:  Angeles Canales-Mayordomo; Rosa Fayos; Jesús Angulo; Rafael Ojeda; Manuel Martín-Pastor; Pedro M Nieto; Manuel Martín-Lomas; Rosa Lozano; Guillermo Giménez-Gallego; Jesús Jiménez-Barbero
Journal:  J Biomol NMR       Date:  2006-07-29       Impact factor: 2.835

3.  Influence of heparin mimetics on assembly of the FGF.FGFR4 signaling complex.

Authors:  Krishna Saxena; Ulrich Schieborr; Oliver Anderka; Elke Duchardt-Ferner; Bettina Elshorst; Santosh Lakshmi Gande; Julia Janzon; Denis Kudlinzki; Sridhar Sreeramulu; Matthias K Dreyer; K Ulrich Wendt; Corentin Herbert; Philippe Duchaussoy; Marc Bianciotto; Pierre-Alexandre Driguez; Gilbert Lassalle; Pierre Savi; Moosa Mohammadi; Françoise Bono; Harald Schwalbe
Journal:  J Biol Chem       Date:  2010-06-14       Impact factor: 5.157

4.  Sequence swapping does not result in conformation swapping for the beta4/beta5 and beta8/beta9 beta-hairpin turns in human acidic fibroblast growth factor.

Authors:  Jaewon Kim; Jihun Lee; Stephen R Brych; Timothy M Logan; Michael Blaber
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

5.  Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interactions affects protein folding.

Authors:  Moreno Zamai; Chithra Hariharan; Dina Pines; Michal Safran; Avner Yayon; Valeria R Caiolfa; Rivka Cohen-Luria; Ehud Pines; Abraham H Parola
Journal:  Biophys J       Date:  2002-05       Impact factor: 4.033

6.  Effect of FGF-binding protein 3 on vascular permeability.

Authors:  Wentao Zhang; Yifan Chen; Matthew R Swift; Elena Tassi; Dora C Stylianou; Krissa A Gibby; Anna T Riegel; Anton Wellstein
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

Review 7.  Heparin-binding domains in vascular biology.

Authors:  Eva M Muñoz; Robert J Linhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-01       Impact factor: 8.311

8.  Structurally homologous all beta-barrel proteins adopt different mechanisms of folding.

Authors:  Thiagarajan Srimathi; Thallampuranam Krishnaswamy S Kumar; Karuppanan Muthusamy Kathir; Ya-Hui Chi; Sampath Srisailam; Wann-Yin Lin; Ing-Ming Chiu; Chin Yu
Journal:  Biophys J       Date:  2003-07       Impact factor: 4.033

Review 9.  CD44 Glycosylation as a Therapeutic Target in Oncology.

Authors:  Chengcheng Liao; Qian Wang; Jiaxing An; Jie Chen; Xiaolan Li; Qian Long; Linlin Xiao; Xiaoyan Guan; Jianguo Liu
Journal:  Front Oncol       Date:  2022-07-21       Impact factor: 5.738

10.  Synthesis of Novel Suramin Analogs With Anti-Proliferative Activity via FGF1 and FGFRD2 Blockade.

Authors:  Nuzhat Parveen; Yan-Liang Lin; Ruey-Hwang Chou; Chung-Ming Sun; Chin Yu
Journal:  Front Chem       Date:  2022-01-03       Impact factor: 5.221

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.